Literature DB >> 2540794

Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.

M B Moore1, J P McCulley.   

Abstract

We examined and treated six patients with acanthamoeba keratitis associated with contact lens wear from 1981 to 1988. Five patients were treated with topical neomycin-polymyxin B-gramicidin (Neosporin) and propamidine isethionate (Brolene) drops. The patients were followed up for an average of 32 months (range 16-75 months). Two patients underwent penetrating keratoplasty at 22 and 26 months after the onset of symptoms and have maintained clear grafts with no evidence of recurrence. In four patients corneal infiltrates cleared on topical medication. All six patients have 6/6 best corrected vision. Early diagnosis and medical treatment alone can result in resolution of corneal infiltrates due to acanthamoebae. With this initial therapy we have had no treatment failures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540794      PMCID: PMC1041712          DOI: 10.1136/bjo.73.4.271

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers.

Authors:  M B Moore; J P McCulley; C Newton; L M Cobo; G N Foulks; D M O'Day; K J Johns; W T Driebe; L A Wilson; R J Epstein
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

Review 2.  Acanthamoeba keratitis. A review of the literature.

Authors:  J D Auran; M B Starr; F A Jakobiec
Journal:  Cornea       Date:  1987       Impact factor: 2.651

3.  In vitro sensitivity of virulent Acanthamoeba culbertsoni to a variety of drugs and antibiotics.

Authors:  A Ferrante; B Rowan-Kelly; Y H Thong
Journal:  Int J Parasitol       Date:  1984-02       Impact factor: 3.981

4.  Acanthamoeba keratitis successfully treated medically.

Authors:  P Wright; D Warhurst; B R Jones
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

5.  Acanthamoeba keratitis associated with soft contact lenses.

Authors:  M B Moore; J P McCulley; M Luckenbach; H Gelender; C Newton; M B McDonald; G S Visvesvara
Journal:  Am J Ophthalmol       Date:  1985-09-15       Impact factor: 5.258

6.  Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis.

Authors:  M B Moore; J P McCulley; H E Kaufman; J B Robin
Journal:  Ophthalmology       Date:  1986-10       Impact factor: 12.079

7.  Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocytosine, hydroxystilbamidine, and other substances.

Authors:  D P Casemore
Journal:  J Clin Pathol       Date:  1970-11       Impact factor: 3.411

8.  Successful medical treatment of a corneal ulcer due to Acanthamoeba polyphaga.

Authors:  T N Jackson; J B Heinze; J Tuxen; J M Weiner
Journal:  Aust N Z J Ophthalmol       Date:  1986-05

9.  Chemotherapeutic compounds and Acanthamoebae from eye infections.

Authors:  J Nagington; J E Richards
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

  9 in total
  10 in total

1.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.

Authors:  Jeena Mascarenhas; Prajna Lalitha; N Venkatesh Prajna; Muthiah Srinivasan; Manoranjan Das; Sean S D'Silva; Catherine E Oldenburg; Durga S Borkar; Elizabeth J Esterberg; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Ophthalmol       Date:  2013-11-05       Impact factor: 5.258

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Practice patterns and opinions in the treatment of acanthamoeba keratitis.

Authors:  Catherine E Oldenburg; Nisha R Acharya; Elmer Y Tu; Michael E Zegans; Mark J Mannis; Bruce D Gaynor; John P Whitcher; Thomas M Lietman; Jeremy D Keenan
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

Review 4.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Delay in diagnosis and outcome of Acanthamoeba keratitis.

Authors:  I Claerhout; A Goegebuer; C Van Den Broecke; Ph Kestelyn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

6.  Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.

Authors:  D Perrine; J P Chenu; P Georges; J C Lancelot; C Saturnino; M Robba
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

7.  Clinical and histologic evaluations of experimental Acanthamoeba keratitis.

Authors:  Zubeyde Akin Polat; Semra Ozcelik; Ayse Vural; Esin Yildiz; Ali Cetin
Journal:  Parasitol Res       Date:  2007-08-14       Impact factor: 2.289

8.  Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.

Authors:  F L Schuster; L S Jacob
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

9.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

10.  In Vitro Activity of Pentamidine Isethionate against Trophozoite and Cyst of Acanthamoeba.

Authors:  Massoud Behnia; Alireza Latifi; Mostafa Rezaian; Sharmin Kharazi; Mehdi Mohebali; Setayesh Yasami; Shiva Saghafi; Reza Chahardoli; Narges Anasori; Hakimeh Torkian; Mohammad Soleimani; Maryam Niyyati; Elham Kazemirad
Journal:  Iran J Parasitol       Date:  2021 Oct-Dec       Impact factor: 1.012

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.